Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
These observations led to an interesting development bifurcation : Melanotan I (Afamelanotide) continued as a skin peptide and in 2014 received approval as Scenesse for erythropoietic protoporphyria (a rare genetic disease with severe photosensitivity) Melanotan II was abandoned as a cutaneous drug PT-141 / Bremelanotide , a fragment of Melanotan II targeted at MC4R, was developed as a sexual stimulant and in 2019 approved as Vyleesi for hypoactive sexual desire disorder in women (HSDD) Second life in research and the cosmetic underground Melanotan II never reached commercial approval as a drug, but in the research community and cosmetic underground it became well known
Potential Treatment for Cognitive Impairment In several intriguing ways, GHK-Cu may help with neurological issues
Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis
Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing Current Pharmaceutical Design, 2018, Volume 24 (Issue 18), Pages 1972-1989
Supports a healthy GI system Encourages gut health Supports tissue regeneration Supports a balanced immune and inflammatory response as well as supporting a myriad of other body systems
US$ 21.63
US$ 24.89
US$ 21.98
US$ 20.65
US$ 25.20
